Federal contractor · public award history
TG THERAPEUTICS INC
Parent: TG THERAPEUTICS INC JKPZKD19WMD7
- Awards we know about
- 2
- Typical size
- —
- Middle of their public awards
- Dollars on those awards
- $0
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Aug 12, 2026
- Activation date
- Aug 14, 2025
- Primary NAICS (SAM)
- 325412
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (2)
Industries & product codes
Award history
- Department of Veterans Affairs—
NEW AWARD FOR UBLITUXIMAB-XIIY 150MG/6ML INJECTION (ANTI-CD20 ANTIBODIES WITH TG THERAPEUTICS. PERIOD OF PERFORMANCE JUNE 17, 2024 - JUNE 16, 2025 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.